Literature DB >> 6478053

Stage-specific sensitivity of spermatogonia to different chemotherapeutic drugs.

M L Meistrich.   

Abstract

The sensitivity of cells at different stages of spermatogenesis in the mouse to various chemotherapeutic drugs will be reviewed in order to compare the actions of related drugs. The rapidly dividing differentiated spermatogonia are most sensitive to all drugs. Cells at later stages, which do not synthesize DNA but still undergo meiotic division, are most resistant. Slowly proliferating spermatogonial stem cells are of intermediate sensitivity. In general, these stem cells are most sensitive to intercalating antibiotics, less sensitive to alkylating agents, and most resistant to antimetabolites, although there are differences between agents within each group. The concept of differential sensitivity of mouse spermatogonia can be used to explain varying durations of sterility in patients treated with different chemotherapeutic drugs, but the results obtained with specific drugs in the mouse may be extrapolated directly to man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478053

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy.

Authors:  M L Meistrich
Journal:  Br J Cancer Suppl       Date:  1986

Review 2.  Preventable causes of male infertility.

Authors:  S T Thompson
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

3.  Cisplatin-induced alterations in the functional spermatogonial stem cell pool and niche in C57/BL/6J mice following a clinically relevant multi-cycle exposure.

Authors:  James G Harman; John H Richburg
Journal:  Toxicol Lett       Date:  2014-04-02       Impact factor: 4.372

4.  Bortezomib treatment causes long-term testicular dysfunction in young male mice.

Authors:  Mi Hou; Emma Eriksson; Konstantin Svechnikov; Kirsi Jahnukainen; Olle Söder; Andreas Meinhardt; Lars Sävendahl
Journal:  Mol Cancer       Date:  2014-06-20       Impact factor: 27.401

5.  Spermatogonial stem cell transplantation into nonablated mouse recipient testes.

Authors:  Hiroko Morimoto; Narumi Ogonuki; Mito Kanatsu-Shinohara; Shogo Matoba; Atsuo Ogura; Takashi Shinohara
Journal:  Stem Cell Reports       Date:  2021-06-17       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.